Serial Number:
88824807
Mark:
TRIS
Status:
Registered
Status Date:
06-22-2021
Filing Date:
Registration Number:
6392554
Registration Date:
06-22-2021
Pharmaceutical preparations, namely, beta-Hydroxy beta-methylglutaryl-CoA (HMG-CoA) reductase inhibitors used to lower LDL cholesterol and to treat hypertriglyceridemia as an adjunct to diet; cholesterol lowering medications; pharmaceutical preparations that act as central nervous system stimulants; pharmaceutical preparations, namely, neuromodulators for treatment of psychiatric disorders and disorders related to attention-deficit hyperactivity disorder; pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); liquid oral pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); solid pharmaceutical preparations for the treatment of attention-deficit hyperactivity disorder (ADHD); pharmaceutical preparations for the treatment of narcolepsy; pharmaceutical preparations for the treatment of chronic lung disease; pharmaceutical preparations for the treatment of colds; pharmaceutical preparations for the treatment of coughs; extended release liquid pharmaceutical preparations for the treatment of coughs; pharmaceutical preparations for the treatment of upper respiratory symptoms; pharmaceutical preparations for the treatment of pain Providing information relating to therapeutic properties of pharmaceutical preparations; providing a website featuring information relating to therapeutic properties of pharmaceutical preparations
Mark Description:
N/A
Class:
Medical services
Type of Mark:
Trademark
Published for Opposition Date:
04-06-2021
Owner:
Mark Drawing Status:
Standart Character Mark
Abandon Date:
N/A
Business Name:
HOWSON & HOWSON, LLP
Correspondent Name:
